{"title":"Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes","authors":"Shreepriya Mangalgi, Silvi Shah","doi":"10.1111/hdi.70062","DOIUrl":null,"url":null,"abstract":"<p>Pregnancy in women with end-stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies. Important maternal adverse outcomes include early pregnancy loss, preeclampsia, polyhydramnios, and cesarean delivery, while common adverse fetal outcomes are preterm birth, low birth weight, and high neonatal intensive care utilization. Evidence consistently demonstrates that dialysis intensification—achieving longer treatment hours or targeting lower maternal blood urea nitrogen levels—correlates with improved gestational age and birth weight, thereby enhancing live birth rates. Optimizing therapy further requires individualized dialysis prescriptions, careful volume and blood pressure management, and timely adjustment of dialysate composition. A multidisciplinary approach involving nephrology, maternal-fetal medicine, obstetrics, gynecology, and neonatology is critical for care coordination. Despite these advances, significant disparities persist, particularly in access to intensive dialysis and specialized care worldwide. Future directions include strengthening obstetric nephrology training, expanding research in peritoneal and home hemodialysis during pregnancy, and establishing integrated care models. With careful planning and optimization of renal replacement therapy, maternal and fetal outcomes in this high-risk population can continue to improve. This review aims to synthesize current evidence on fertility, dialysis strategies, and maternal–fetal outcomes in pregnant women with ESKD on dialysis, while highlighting practical considerations for dialysis optimization and multidisciplinary care, thereby addressing gaps in consolidated guidance for clinicians managing this increasingly encountered high-risk population.</p>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"30 3","pages":"499-507"},"PeriodicalIF":1.4000,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.70062","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.70062","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pregnancy in women with end-stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies. Important maternal adverse outcomes include early pregnancy loss, preeclampsia, polyhydramnios, and cesarean delivery, while common adverse fetal outcomes are preterm birth, low birth weight, and high neonatal intensive care utilization. Evidence consistently demonstrates that dialysis intensification—achieving longer treatment hours or targeting lower maternal blood urea nitrogen levels—correlates with improved gestational age and birth weight, thereby enhancing live birth rates. Optimizing therapy further requires individualized dialysis prescriptions, careful volume and blood pressure management, and timely adjustment of dialysate composition. A multidisciplinary approach involving nephrology, maternal-fetal medicine, obstetrics, gynecology, and neonatology is critical for care coordination. Despite these advances, significant disparities persist, particularly in access to intensive dialysis and specialized care worldwide. Future directions include strengthening obstetric nephrology training, expanding research in peritoneal and home hemodialysis during pregnancy, and establishing integrated care models. With careful planning and optimization of renal replacement therapy, maternal and fetal outcomes in this high-risk population can continue to improve. This review aims to synthesize current evidence on fertility, dialysis strategies, and maternal–fetal outcomes in pregnant women with ESKD on dialysis, while highlighting practical considerations for dialysis optimization and multidisciplinary care, thereby addressing gaps in consolidated guidance for clinicians managing this increasingly encountered high-risk population.
期刊介绍:
Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis.
The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.